These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 18482813

  • 1. [Treatment of hepatitis C: therapeutic management].
    Bourliere M.
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract] [Full Text] [Related]

  • 2. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS, Rao GA, Bulchandani D, Pandya PK, Alba LM.
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prevention of adverse effects in ribavirin and interferon combination therapy].
    Izumi N.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):523-7. PubMed ID: 15359855
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK, Kaplan AL.
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [Abstract] [Full Text] [Related]

  • 8. [Quality of life of patients with chronic hepatitis C: effect of treatments].
    Couzigou P.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B257-63. PubMed ID: 12180299
    [No Abstract] [Full Text] [Related]

  • 9. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P, Staufer K.
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO, Schuchmann M, Link R, Hillenbrand H, Rahman F, Sprinzl M, Mudter J, Löhr HF, Galle PR.
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X.
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract] [Full Text] [Related]

  • 14. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S.
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [Abstract] [Full Text] [Related]

  • 15. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
    Sharvadze L, Gochitashvili N, Tophuria A, Bolokadze N, Tsertsvadze T.
    Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-induced central retinal vein thrombosis.
    Nazir L, Husain A, Haroon W, Shaikh MI, Mirza SA, Khan Z.
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):735-6. PubMed ID: 23146860
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.